UK markets closed

Stereotaxis, Inc. (STXS)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
2.6100+0.1000 (+3.98%)
At close: 04:00PM EDT
2.6300 +0.02 (+0.77%)
After hours: 04:40PM EDT

Stereotaxis, Inc.

710 North Tucker Boulevard
Suite 110
Saint Louis, MO 63101
United States
314 678 6100
https://www.stereotaxis.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees122

Key executives

NameTitlePayExercisedYear born
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.CEO & Chairman62.2kN/A1987
Ms. Kimberly R. PeeryCFO & Secretary251.84kN/A1969
Mr. Keith GallowayVice President of OperationsN/AN/AN/A
Ms. Laura Spencer GarthGeneral Counsel & SecretaryN/AN/AN/A
Mr. Guy JudkowskiEquity Portfolio ManagerN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Corporate governance

Stereotaxis, Inc.’s ISS governance QualityScore as of 1 March 2024 is 8. The pillar scores are Audit: 8; Board: 8; Shareholder rights: 9; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.